0000950170-24-033845.txt : 20240319 0000950170-24-033845.hdr.sgml : 20240319 20240319195815 ACCESSION NUMBER: 0000950170-24-033845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tada Hiroomi CENTRAL INDEX KEY: 0001880593 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 24765852 MAIL ADDRESS: STREET 1: C/O TYRA BIOSCIENCES, INC STREET 2: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831476348 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 ownership.xml 4 X0508 4 2024-03-15 0001863127 Tyra Biosciences, Inc. TYRA 0001880593 Tada Hiroomi C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 false true false false Chief Medical Officer false Common Stock 2024-03-15 4 A false 1968 6.5790 A 86435 D These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan. /s/ Ali D. Fawaz, Attorney-in-Fact 2024-03-19